Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of omitting regional nodal irradiation in cT1-2N1 breast cancer with ypN1 disease after neoadjuvant chemotherapy (KROG 21-06).

Clinical and translational radiation oncology·2026
Same author

Gut-derived, inflammatory ILC2s disseminate type 2 immunity to remote lung in food allergen-challenged mice.

Journal of leukocyte biology·2026
Same author

Qualitative beta-2-adrenoceptor signaling in the regulation of human airway epithelia mucin and cytokine production.

Respiratory research·2026
Same author

Amoxicillin induces gut dysbiosis leading to long term suppression of type-17 immune tone in the lungs.

bioRxiv : the preprint server for biology·2026
Same author

Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases.

Breast (Edinburgh, Scotland)·2026
Same author

Survey Study on the Patterns of Practice for Pancreatic Cancer Radiation Therapy in Korea.

Journal of medical imaging and radiation oncology·2026
Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026
Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Mucus hypersecretion in asthma: causes and effects.

Christopher M Evans1, Kyubo Kim, Michael J Tuvim

  • 1Department of Pulmonary Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-1402, USA.

Current Opinion in Pulmonary Medicine
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Asthma mucus plugging is linked to MUC5AC overproduction and secretion. Targeting MUC5AC may treat asthma without affecting normal airway function, as MUC5B is crucial for homeostasis.

More Related Videos

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

Related Experiment Videos

Last Updated: Jun 27, 2026

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer
08:47

Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

Published on: April 21, 2022

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins
09:24

Mucin Agarose Gel Electrophoresis: Western Blotting for High-molecular-weight Glycoproteins

Published on: June 14, 2016

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Respiratory Physiology

Background:

  • Airway mucus plugging is a major cause of asthma mortality.
  • The molecular mechanisms of mucin overproduction and secretion in asthma were previously unclear.
  • Understanding these pathways is crucial for managing lung pathophysiology.

Purpose of the Study:

  • To review the molecular mechanisms of mucin overproduction and secretion in the airways.
  • To investigate the roles of specific mucins (MUC5AC and MUC5B) in airway homeostasis and inflammation.
  • To explore potential therapeutic strategies targeting mucin pathways in asthma.

Main Methods:

  • Review of existing literature on airway mucin production and secretion.
  • Analysis of the roles of MUC5AC and MUC5B in human and mouse airways.
  • Investigation of regulatory factors such as Foxa2 and HIF-1 in mucin production.
  • Examination of the signaling pathways involved in mucin secretion, including P2Y2 receptors and triphosphate nucleotides.

Main Results:

  • MUC5B is the primary gel-forming mucin in normal small airways, essential for homeostasis.
  • MUC5AC is upregulated during airway inflammation and is regulated by Foxa2 and HIF-1.
  • Mucin secretion is regulated independently of production, primarily by extracellular triphosphate nucleotides acting on P2Y2 receptors.
  • Specific proteins like Munc13-2 and synaptotagmin-2 are involved in activating mucin exocytosis.

Conclusions:

  • Upregulated MUC5AC production and secretion contribute significantly to airflow obstruction in asthma.
  • Selective inhibition of MUC5AC may offer a therapeutic approach for asthma without compromising essential homeostatic functions mediated by MUC5B.
  • Further research is needed to define the exact roles of mucin hypersecretion in asthma symptoms and physiological changes.